New WHO Access Platform Could Mean Tiered Pricing In Europe
New platform for finding solutions to increase access to expensive medicines should ensure sustainability of health care systems and pharmaceutical industry and could include tiered pricing models.
You may also be interested in...
Equitable access to medicines for all is the bold aim of a collaborative European initiative backed by the WHO and Norway that is now moving into its more technical second phase.
Brazil’s health technology assessment institute is to incorporate cost-effectiveness thresholds into its decision making.
Companies selling orphan medicines in the Netherlands need to prepare for the likelihood that their products will enter the so-called lock system, which means they will come under extra scrutiny and take longer to reach patients.